RAASi is the foundational therapy for patients with heart failure and/or chronic kidney disease. But when these patients experience episodes of hyperkalemia RAASi therapy is often down-titrated or discontinued. In this program, a multidisciplinary faculty discusses how to navigate hyperkalemia in patients with cardiorenal disease.
This course consists of 3 episodes. Watch all episodes, answer pre- and post-test questions, and start earning CME credits.
Facebook Comments